Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma

Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKn...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Valerie Schmelter, Sarah Heidorn, Alexander Muacevic, Siegfried G. Priglinger, Paul Foerster, Raffael Liegl
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e167f958b78a4d7e9e17836f0ebcad5a
record_format dspace
spelling oai:doaj.org-article:e167f958b78a4d7e9e17836f0ebcad5a2021-12-02T15:53:03ZRobotic assisted CyberKnife radiosurgery for the treatment of iris melanoma10.1038/s41598-021-84290-x2045-2322https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84290-xhttps://doaj.org/toc/2045-2322Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKnife treatment. Consecutive patients from the Department of Ophthalmology at University of Munich were included in the study if they had an iris melanoma that was treated with CyberKnife and had a minimum follow-up of 12 months. We evaluated tumor thickness, largest diameter, visual acuity and complications. 8 patients were included in this report. The median age was 74 years (range: 53–86 years). The median follow-up was 23 months (range 12–48 months). Tumor thickness decreased from 2.1 to 1.4 mm on average. Four out of eight patients showed stable or increased visual acuity compared to visual acuity at first visit. We did not find a correlation of applied radiation volume or radiation dose on visual outcome. Radiation keratopathy was the most common complication in five patients. No recurrences were noted. Robotic-assisted radiosurgery following CyberKnife is a promising non-invasive, single session treatment option for iris melanoma with comparable results regarding recurrence rate or complications to brachytherapy and proton beam therapy. All included patients showed good visual outcome.Valerie SchmelterSarah HeidornAlexander MuacevicSiegfried G. PriglingerPaul FoersterRaffael LieglNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Valerie Schmelter
Sarah Heidorn
Alexander Muacevic
Siegfried G. Priglinger
Paul Foerster
Raffael Liegl
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
description Abstract Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in eight patients with iris melanoma following robotic-assisted CyberKnife treatment. Consecutive patients from the Department of Ophthalmology at University of Munich were included in the study if they had an iris melanoma that was treated with CyberKnife and had a minimum follow-up of 12 months. We evaluated tumor thickness, largest diameter, visual acuity and complications. 8 patients were included in this report. The median age was 74 years (range: 53–86 years). The median follow-up was 23 months (range 12–48 months). Tumor thickness decreased from 2.1 to 1.4 mm on average. Four out of eight patients showed stable or increased visual acuity compared to visual acuity at first visit. We did not find a correlation of applied radiation volume or radiation dose on visual outcome. Radiation keratopathy was the most common complication in five patients. No recurrences were noted. Robotic-assisted radiosurgery following CyberKnife is a promising non-invasive, single session treatment option for iris melanoma with comparable results regarding recurrence rate or complications to brachytherapy and proton beam therapy. All included patients showed good visual outcome.
format article
author Valerie Schmelter
Sarah Heidorn
Alexander Muacevic
Siegfried G. Priglinger
Paul Foerster
Raffael Liegl
author_facet Valerie Schmelter
Sarah Heidorn
Alexander Muacevic
Siegfried G. Priglinger
Paul Foerster
Raffael Liegl
author_sort Valerie Schmelter
title Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
title_short Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
title_full Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
title_fullStr Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
title_full_unstemmed Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
title_sort robotic assisted cyberknife radiosurgery for the treatment of iris melanoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e167f958b78a4d7e9e17836f0ebcad5a
work_keys_str_mv AT valerieschmelter roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
AT sarahheidorn roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
AT alexandermuacevic roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
AT siegfriedgpriglinger roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
AT paulfoerster roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
AT raffaelliegl roboticassistedcyberkniferadiosurgeryforthetreatmentofirismelanoma
_version_ 1718385542704398336